 Diversified Trust Co purchased a new stake in GlycoMimetics Inc NASDAQ:GLYC in the 2nd quarter, according to its most recent filing with the SEC. The fund purchased 15,522 shares of the biotechnology companys stock, valued at approximately 58,000. A number of other institutional investors and hedge funds have also modified their holdings of the business. ... 